生物学的イメージング試薬の世界市場レポート 2025年

生物学的イメージング試薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.2％で277億8,000万米ドルに成長します。予測期間における成長の背景には、医薬品開発におけるアプリケーションの拡大、分子イメージングに対する需要の高まり、非侵襲的診断法への注目、世界のがん患者の増加、価値ベースのヘルスケアへのシフトなどがあります。予測期間における主な動向としては、造影剤需要の増加、標的分子イメージング剤の開発、イメージングにおけるナノ粒子の応用、in vivoイメージング用蛍光プローブの出現、画像解析における人工知能の統合などが挙げられます。

慢性疾患の増加は、今後の生物学的イメージング試薬市場の成長を牽引すると予測されています。慢性疾患は、継続的な医療を必要とし、時間の経過とともに悪化する可能性のある、1年以上持続する疾患と定義されます。これらの疾患では、臓器や罹患した構造を視覚化することによって問題を診断し特定するために、生物学的イメージング試薬を使用する必要があります。例えば、米国を拠点とする任意団体である米国がん協会は、2022年に米国で新たにがんと診断される患者数は190万人、がんによる死亡者数は609,360人になると推定しています。さらに、2023年1月、米国を拠点とする国立医学図書館は、米国で少なくとも1つの慢性疾患を持つ50歳以上の個人の数が99.5％増加し、2050年までに7,152万2,000人から1億4,266万人に増加する見込みであると報告しました。このように、慢性疾患の蔓延が生物学的イメージング試薬市場の拡大に拍車をかけています。

個別化医療に対する需要の高まりが、生物学的イメージング試薬市場の成長に寄与すると予測されています。個別化医療は、生物学的イメージング試薬を活用して分子・細胞レベルの生物学的プロセスを可視化することで、ヘルスケアに関する意思決定や治療を個々の患者の特性に合わせるものです。2022年、米国食品医薬品局（FDA）の医薬品評価研究センター（Center for Drug Evaluation and Research）は37の新規分子実体を承認し、その約34％（12）は個別化医療連合（Personalized Medicine Coalition）によって個別化医療に分類されました。このような個別化医療に対する需要の高まりが、生物学的イメージング試薬市場を牽引する大きな要因となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界生物学的イメージング試薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の生物学的イメージング試薬市場：成長率分析
• 世界の生物学的イメージング試薬市場の実績：規模と成長, 2019-2024
• 世界の生物学的イメージング試薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界生物学的イメージング試薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の生物学的イメージング試薬市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 造影剤
• 光学イメージング試薬
• 放射性医薬品
• 世界の生物学的イメージング試薬市場：モダリティ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 磁気共鳴画像（MRI）
• 超音波
• X線とコンピュータ断層撮影（CT）
• 核
• 光学イメージング
• その他のモダライト
• 世界の生物学的イメージング試薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• In vitro（体外）
• In vivo
• 世界の生物学的イメージング試薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断検査室
• 画像診断センター
• ライフサイエンス企業
• 調査・学術機関
• その他のエンドユーザー
• 世界の生物学的イメージング試薬市場、造影剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• X線造影剤
• MRI造影剤
• 超音波造影剤
• 世界の生物学的イメージング試薬市場、光学イメージング試薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 蛍光染料
• 生物発光試薬
• 量子ドット
• 世界の生物学的イメージング試薬市場放射性医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 診断用放射性医薬品
• 治療用放射性医薬品

第7章 地域別・国別分析

• 世界の生物学的イメージング試薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の生物学的イメージング試薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 生物学的イメージング試薬市場：競合情勢
• 生物学的イメージング試薬市場：企業プロファイル
  • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson And Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer Healthcare AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Dickinson and Company（BD）
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.
• Stryker Corporation
• FluoroPharma Medical Inc.
• Lonza Group AG
• Illumina Inc.
• PerkinElmer Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories Inc.
• Bracco Diagnostics Inc.
• Leica Microsystems GmbH
• Lantheus Medical Imaging Inc.
• Guerbet SA
• Miltenyi Biotec B.V. and Co. KG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 生物学的イメージング試薬市場2029：新たな機会を提供する国
• 生物学的イメージング試薬市場2029：新たな機会を提供するセグメント
• 生物学的イメージング試薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Biologic imaging reagents encompass substances or compounds employed in diverse imaging techniques to augment the visibility and contrast of biological structures, molecules, or processes. These reagents are specifically designed to interact with distinct biological targets, such as proteins, nucleic acids, or cellular structures, thereby enhancing their visibility and distinguishability during imaging.

The primary categories of products within biologic imaging reagents include contrast reagents, optical imaging reagents, and radiopharmaceuticals. Contrast reagents are substances utilized in medical imaging to amplify the visibility of specific tissues. This encompasses various modalities such as magnetic resonance imaging (MRI), ultrasound, x-ray, and computerized tomography (CT), nuclear, optical, and others, applied in various contexts, including in vitro and in vivo. Diagnostic laboratories, imaging centers, life science companies, research and academic institutes, and other entities make use of these reagents.

The biologic imaging reagents market research report is one of a series of new reports from The Business Research Company that provides biologic imaging reagents market statistics, including biologic imaging reagents industry global market size, regional shares, competitors with a biologic imaging reagents market share, detailed biologic imaging reagents market segments, market trends and opportunities, and any further data you may need to thrive in the biologic imaging reagents industry. This biologic imaging reagents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biologic imaging reagents market size has grown rapidly in recent years. It will grow from $18.41 billion in 2024 to $20.26 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to rise in prevalence of chronic diseases, growing research and development investments, shift towards personalized medicine, focus on early disease detection, increasing geriatric population, collaborations in biomedical research.

The biologic imaging reagents market size is expected to see strong growth in the next few years. It will grow to $27.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to expanding applications in drug development, rising demand for molecular imaging, focus on non-invasive diagnostic methods, global increase in cancer cases, shift towards value-based healthcare. Major trends in the forecast period include rise in demand for contrast-enhanced imaging agents, development of targeted molecular imaging agents, application of nanoparticles in imaging, emergence of fluorescent probes for in vivo imaging, integration of artificial intelligence in image analysis.

The rising prevalence of chronic diseases is anticipated to drive the growth of the biologic imaging reagents market in the future. Chronic diseases are defined as conditions lasting one year or longer that require ongoing medical care and may deteriorate over time. These diseases necessitate the use of biologic imaging reagents to diagnose and identify issues by visualizing organs and affected structures. For example, in 2022, the American Cancer Society, a US-based voluntary organization, estimated that there would be 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. Additionally, in January 2023, the National Library of Medicine, a US-based agency, reported that the number of individuals aged 50 and older in the US with at least one chronic condition is expected to increase by 99.5%, rising from 71.522 million to 142.66 million by 2050. Thus, the growing prevalence of chronic diseases is fueling the expansion of the biologic imaging reagents market.

The increasing demand for personalized medicine is anticipated to contribute to the growth of the biologic imaging reagents market. Personalized medicine tailors healthcare decisions and treatments to individual patient characteristics, utilizing biologic imaging reagents to visualize biological processes at the molecular and cellular level. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research approved 37 new molecular entities, with approximately 34% (12) classified as personalized medicines by the Personalized Medicine Coalition. This growing demand for personalized medicine is a significant factor driving the biologic imaging reagents market.

Major players in the biologic imaging reagents market are dedicating their efforts to the development of innovative reagents, particularly novel dye technology, providing a new tool for researchers and clinicians to enhance the sensitivity and specificity of biologic imaging. Novel dye technology involves the creation of new dyes for various applications, including biological imaging. In April 2022, Becton, Dickinson, and Company, a US-based medical device company, introduced BD Horizon RealYellow 586 Reagents and RealBlue Reagents. This new line of reagents enables researchers to obtain higher data resolution and more insights from samples compared to standard fluorochrome. The improvement is attributed to the incorporation of revolutionary dye technology and artificial intelligence (AI) supervision. The AI analyzed existing data from excitation and emission profiles of commercially available fluorochromes, determining optimal positions in laser lines for the development of novel dyes.

In October 2024, Bracco S.p.A, an Italy-based healthcare company specializing in biological imaging reagents, entered into a partnership with Subtle Medical. This collaboration aims to combine Bracco's expertise in contrast imaging with deep-learning technology to redefine diagnostic precision and efficiency in medical imaging. Additionally, Bracco S.p.A received approval from the Food and Drug Administration (FDA), a US federal agency, for its AI-powered software, AiMIFY, which is classified as Class II software as a medical device (SaMD) specifically designed to enhance magnetic resonance imaging (MRI) of the brain. Subtle Medical is a US-based healthcare technology company.

Major companies operating in the biologic imaging reagents market report are Cardinal Health Inc., Johnson And Johnson Services Inc., Bayer Healthcare AG, Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Dickinson and Company (BD), Koninklijke Philips N.V., GE HealthCare Technologies Inc., Stryker Corporation, FluoroPharma Medical Inc., Lonza Group AG, Illumina Inc., PerkinElmer Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Bracco Diagnostics Inc., Leica Microsystems GmbH, Lantheus Medical Imaging Inc., Guerbet SA, Miltenyi Biotec B.V. and Co. KG, Promega Corporation, Abcam plc., Luminex Corporation, MILabs, LI-COR Biosciences, FUJIFILM VisualSonics Inc., Advanced Proteome Therapeutics Incorporated, BIOPRO Baden-Wurttemberg GmbH, ABX Advanced Biochemical Compounds GmbH

North America was the largest region in the biologic imaging reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologic imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biologic imaging reagents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biologic imaging reagents market consists of sales of gadolinium-based contrast agents, iodinated contrast agents, microbubbles, nanoparticles, bioluminescent probes, immunohistochemistry reagents, optical imaging agents, paramagnetic agents and fluorescent dyes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biologic Imaging Reagents Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologic imaging reagents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologic imaging reagents ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologic imaging reagents market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Contrast Reagents; Optical Imaging Reagents; Radiopharmaceuticals
• 2) By Modality: Magnetic Resonance Imaging (MRI); Ultrasound; X-Ray And Computerized Tomography (CT); Nuclear; Optical Imaging; Other Modalities
• 3) By Application: In Vitro; In Vivo
• 4) By End User: Diagnostic Laboratories; Imaging Centers; Life Science Companies; Research And Academic Institutes; Other End Users
• Subsegments:
• 1) By Contrast Reagents: X-ray Contrast Agents; MRI Contrast Agents; Ultrasound Contrast Agents
• 2) By Optical Imaging Reagents: Fluorescent Dyes; Bioluminescent Reagents; Quantum Dots
• 3) By Radiopharmaceuticals: Diagnostic Radiopharmaceuticals; Therapeutic Radiopharmaceuticals
• Companies Mentioned: Cardinal Health Inc.; Johnson And Johnson Services Inc.; Bayer Healthcare AG; Thermo Fisher Scientific Inc.; Siemens Healthcare GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biologic Imaging Reagents Market Characteristics

3. Biologic Imaging Reagents Market Trends And Strategies

4. Biologic Imaging Reagents Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Biologic Imaging Reagents Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biologic Imaging Reagents PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biologic Imaging Reagents Market Growth Rate Analysis
• 5.4. Global Biologic Imaging Reagents Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biologic Imaging Reagents Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biologic Imaging Reagents Total Addressable Market (TAM)

6. Biologic Imaging Reagents Market Segmentation

• 6.1. Global Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contrast Reagents
• Optical Imaging Reagents
• Radiopharmaceuticals
• 6.2. Global Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Magnetic Resonance Imaging (MRI)
• Ultrasound
• X-Ray And Computerized Tomography (CT)
• Nuclear
• Optical Imaging
• Other Modalites
• 6.3. Global Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In Vitro
• In Vivo
• 6.4. Global Biologic Imaging Reagents Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Laboratories
• Imaging Centres
• Life Science Companies
• Research And Academic Institutes
• Other End Users
• 6.5. Global Biologic Imaging Reagents Market, Sub-Segmentation Of Contrast Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• X-ray Contrast Agents
• MRI Contrast Agents
• Ultrasound Contrast Agents
• 6.6. Global Biologic Imaging Reagents Market, Sub-Segmentation Of Optical Imaging Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluorescent Dyes
• Bioluminescent Reagents
• Quantum Dots
• 6.7. Global Biologic Imaging Reagents Market, Sub-Segmentation Of Radiopharmaceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostic Radiopharmaceuticals
• Therapeutic Radiopharmaceuticals

7. Biologic Imaging Reagents Market Regional And Country Analysis

• 7.1. Global Biologic Imaging Reagents Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biologic Imaging Reagents Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biologic Imaging Reagents Market

• 8.1. Asia-Pacific Biologic Imaging Reagents Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biologic Imaging Reagents Market

• 9.1. China Biologic Imaging Reagents Market Overview
• 9.2. China Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biologic Imaging Reagents Market

• 10.1. India Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biologic Imaging Reagents Market

• 11.1. Japan Biologic Imaging Reagents Market Overview
• 11.2. Japan Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biologic Imaging Reagents Market

• 12.1. Australia Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biologic Imaging Reagents Market

• 13.1. Indonesia Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biologic Imaging Reagents Market

• 14.1. South Korea Biologic Imaging Reagents Market Overview
• 14.2. South Korea Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biologic Imaging Reagents Market

• 15.1. Western Europe Biologic Imaging Reagents Market Overview
• 15.2. Western Europe Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biologic Imaging Reagents Market

• 16.1. UK Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biologic Imaging Reagents Market

• 17.1. Germany Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biologic Imaging Reagents Market

• 18.1. France Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biologic Imaging Reagents Market

• 19.1. Italy Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biologic Imaging Reagents Market

• 20.1. Spain Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biologic Imaging Reagents Market

• 21.1. Eastern Europe Biologic Imaging Reagents Market Overview
• 21.2. Eastern Europe Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biologic Imaging Reagents Market

• 22.1. Russia Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biologic Imaging Reagents Market

• 23.1. North America Biologic Imaging Reagents Market Overview
• 23.2. North America Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biologic Imaging Reagents Market

• 24.1. USA Biologic Imaging Reagents Market Overview
• 24.2. USA Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biologic Imaging Reagents Market

• 25.1. Canada Biologic Imaging Reagents Market Overview
• 25.2. Canada Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biologic Imaging Reagents Market

• 26.1. South America Biologic Imaging Reagents Market Overview
• 26.2. South America Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biologic Imaging Reagents Market

• 27.1. Brazil Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biologic Imaging Reagents Market

• 28.1. Middle East Biologic Imaging Reagents Market Overview
• 28.2. Middle East Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biologic Imaging Reagents Market

• 29.1. Africa Biologic Imaging Reagents Market Overview
• 29.2. Africa Biologic Imaging Reagents Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biologic Imaging Reagents Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biologic Imaging Reagents Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biologic Imaging Reagents Market Competitive Landscape And Company Profiles

• 30.1. Biologic Imaging Reagents Market Competitive Landscape
• 30.2. Biologic Imaging Reagents Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson And Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer Healthcare AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Siemens Healthcare GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Biologic Imaging Reagents Market Other Major And Innovative Companies

• 31.1. Dickinson and Company (BD)
• 31.2. Koninklijke Philips N.V.
• 31.3. GE HealthCare Technologies Inc.
• 31.4. Stryker Corporation
• 31.5. FluoroPharma Medical Inc.
• 31.6. Lonza Group AG
• 31.7. Illumina Inc.
• 31.8. PerkinElmer Inc.
• 31.9. Becton, Dickinson and Company
• 31.10. Bio-Rad Laboratories Inc.
• 31.11. Bracco Diagnostics Inc.
• 31.12. Leica Microsystems GmbH
• 31.13. Lantheus Medical Imaging Inc.
• 31.14. Guerbet SA
• 31.15. Miltenyi Biotec B.V. and Co. KG

32. Global Biologic Imaging Reagents Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biologic Imaging Reagents Market

34. Recent Developments In The Biologic Imaging Reagents Market

35. Biologic Imaging Reagents Market High Potential Countries, Segments and Strategies

• 35.1 Biologic Imaging Reagents Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biologic Imaging Reagents Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biologic Imaging Reagents Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer